Cittadino Evelina, Botta Mauro, Tei Lorenzo, Kielar Filip, Stefania Rachele, Chiavazza Enrico, Aime Silvio, Terreno Enzo
Department of Molecular Biotechnology and Health Sciences, Molecular Imaging Center, Università di Torino, Via Nizza 52, 10126 Torino (Italy).
Department of Scienze e Innovazione Tecnologica, Università del Piemonte Orientale "Amedeo Avogadro", Viale T. Michel 11, 15121 Alessandria (Italy).
Chempluschem. 2013 Jul;78(7):712-722. doi: 10.1002/cplu.201300096. Epub 2013 Jun 3.
The magnetic resonance imaging (MRI) performance of two liposome formulations incorporating amphiphilic 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-like Gd complexes has been investigated both in vitro and in vivo. The complexes differ in one donor group of the coordination cage (carboxylate versus carboxoamide), and in the length (C versus C ) and the point of attachment of the aliphatic chains to the chelators. The in vitro H relaxometric characterisation of the systems, performed with a newly developed relaxation model that takes into account the contributions of the Gd chelates pointing in- and outwards of the liposome, indicates that their efficacy is optimal in the range 0.5-1.5 T. The tetracarboxylic C -containing liposomes (LIPO-GdDOTA(GAC ) ; GA=glutaric acid) are four-fold more efficient than the monoamide C -based analogue (LIPO-GdDOTAMA(C ) ). Such a difference is also found in vivo at 1 T in a melanoma tumour model on mice. A few hours after intravenous injection, the T contrast enhancement in the organs where the nanovesicles typically distribute (liver, spleen, kidneys and tumour) is much higher for LIPO-GdDOTA(GAC ) . Interestingly, after about 7 h post-injection the contrast enhancement observed for the more efficient liposomes decreases rapidly and becomes lower than for LIPO-GdDOTAMA(C ) . The relaxometric data and the quantification of the Gd complexes in the organs, determined ex vivo by inductively coupled plasma mass spectrometry, indicate that: 1) the differences in the contrast enhancement can be attributed to the different rate of water exchange and rotational dynamics of the Gd complexes, and 2) the rapid contrast decrease is caused by a faster clearance of GdDOTA(GAC ) from the organs. This is also confirmed by using a newly synthesised amphiphilic cyanine-based fluorescent probe (Cy5-(C ) ). As one of the main limitations for the clinical translation of liposomes incorporating amphiphilic imaging agents is related to their very long persistence in the body, the results reported herein suggest that the clearance of the probes can be accelerated, without compromising their role, by a proper selection of the lipophilic portion of the incorporated compound as well as of the ligand site at which the aliphatic tails are linked. Then, GdDOTA(GAC ) complex may represent a good candidate for the development of improved MRI protocols based on paramagnetically labelled lipidic nanoparticles.
研究了两种包含两亲性1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)类钆配合物的脂质体制剂的磁共振成像(MRI)性能,包括体外和体内研究。这两种配合物在配位笼的一个供体基团(羧酸盐对羧酰胺)、脂肪链的长度(C对C)以及脂肪链与螯合剂的连接点上存在差异。使用一种新开发的弛豫模型对系统进行体外氢弛豫表征,该模型考虑了指向脂质体内外的钆螯合物的贡献,结果表明它们在0.5-1.5 T范围内效果最佳。含四羧酸C的脂质体(LIPO-GdDOTA(GAC);GA=戊二酸)比单酰胺C基类似物(LIPO-GdDOTAMA(C))效率高四倍。在小鼠黑色素瘤肿瘤模型中,在1 T的体内实验中也发现了这种差异。静脉注射后几小时,LIPO-GdDOTA(GAC)在纳米囊泡通常分布的器官(肝脏、脾脏、肾脏和肿瘤)中的T对比度增强要高得多。有趣的是,注射后约7小时,效率更高的脂质体的对比度增强迅速下降,并低于LIPO-GdDOTAMA(C)。弛豫数据以及通过电感耦合等离子体质谱体外测定的器官中钆配合物的定量结果表明:1)对比度增强的差异可归因于钆配合物水交换速率和旋转动力学的不同,2)对比度的快速下降是由于GdDOTA(GAC)从器官中更快地清除。使用新合成的两亲性花青基荧光探针(Cy5-(C))也证实了这一点。由于包含两亲性成像剂的脂质体临床转化的主要限制之一与其在体内的很长停留时间有关,本文报道的结果表明,通过适当选择掺入化合物的亲脂部分以及脂肪链连接的配体位点,可以加速探针的清除,而不影响其作用。因此,GdDOTA(GAC)配合物可能是基于顺磁性标记脂质纳米颗粒开发改进MRI方案的良好候选物。